A1M PHARMA

a1m-pharma-logo

A1M Pharma alpha 1 microglobulin, a body protein that is of major importance for the body's defense against oxidative stress.

#SimilarOrganizations #Website #More

A1M PHARMA

Social Links:

Industry:
Health Care Medical Pharmaceutical

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.a1m.se

Status:
Active

Contact:
+46 46 286 50 30

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins


Similar Organizations

double-wood-logo

Double wood

Double wood is providing high-quality dietary supplements and keeping you in the know about industry-related news and research.

novo-nordisk-logo

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Official Site Inspections

http://www.a1m.se

  • Host name: 192.36.52.200
  • IP address: 192.36.52.200
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "A1M Pharma"

A1M Pharma - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +46 46 286 50 30 A1M Pharma alpha 1 microglobulin, a body protein that is of major importance for the body's defense against โ€ฆSee details»

A1M Pharma - Overview, News & Similar companies | ZoomInfo.com

The company's Certified Advisor is Erik Penser Bank AB, tel. +46 (0)8-463 83 00, [email protected]. This constitutes information that A1M Pharma AB (publ) is โ€ฆSee details»

A1M Pharma AB: Shareholders, Shareholding Structure

A1M Pharma AB is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based โ€ฆSee details»

Company A1M Pharma AB Swiss Exchange - MarketScreener.com

A1M Pharma AB: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Swiss Exchange: | Swiss ExchangeSee details»

A1M Pharma - Products, Competitors, Financials, Employees, โ€ฆ

A1M Pharma is a company focused on providing information about pharmaceuticals. Use the CB Insights Platform to explore A1M Pharma's full profile. Technology Vendors; Recent Research โ€ฆSee details»

A1M Pharma AB - Life-Sciences-Europe.com

Sep 15, 2012 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ€“ the European Association of Bioindustries ... A1M Pharma โ€ฆSee details»

A1M Pharma AB: Contact Details and Business Profile

A1M Pharma develops a diagnostic method and treatment for pre-eclampsia, a condition that affects around 10 million pregnant women worldwide each year. This disorder is responsible โ€ฆSee details»

A1M Pharma AB - life-sciences-europe.com

Upcoming Events. ChinaBio Partnering Forum 2023 Shanghai; BioSpain 2023 Barcelona; ILMAC 2023 Basel; BioCap Conference 2023 Alderley Park; BIO-Europe 2023 München (Munich)See details»

A1m Pharma AB - Overview, Competitors and Decision Makers โ€ฆ

A1m Pharma ABis headquartered in Sweden, Lund - specialized in Biotechnology - Find employees, decision makers, competitors and company information. DataLead allows to โ€ฆSee details»

A1M Pharma - VentureRadar

Guard Therapeutics (fka A1M Pharma) Sweden Publicly Traded Guard Therapeutics aims to develop and commercialize the lead drug candidate ROSgard, and thereby contribute to a โ€ฆSee details»

A1M Pharma - Company Information, Competitors, News & FAQs

Find useful insights on A1M Pharma's company details, tech stack, news alerts, competitors and more. ... a1m.se. Type. N/A. A1M Pharma Technology Stack. Find prospects by the โ€ฆSee details»

A1M Pharma - Guard Therapeutics

While A1M Pharma has struggled to find the optimal path forward for ROSgard over its long history, it now benefits from a clear story. Under new CEO Tobias Agervald and other new โ€ฆSee details»

Articles about A1M Pharma - BioSpace

7 articles about A1M Pharma. A1M Pharma To Raise SEK 213 Million For Phase I/II ROSGard PPRT Kidney Damage Trials. 3/31/2017. A1M Pharma Has Successfully Conducted โ€ฆSee details»

Governance A1M Pharma AB Nasdaq Stockholm

Find the composition of the Board of Directors of A1M Pharma AB (Nasdaq Stockholm Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»

Nasdaq Stockholm Welcomes A1M Pharma to First North

Stockholm, June 20, 2017 โ€” Nasdaq (Nasdaq: NDAQ) announces that the trading in A1M Pharma ABโ€™s shares (short name: A1M) commenced today on Nasdaq First North in โ€ฆSee details»

Nasdaq Stockholm Welcomes A1M Pharma to First North

Jun 20, 2017 Founded in 2008 by researchers at Lund University, A1M Pharma is a biotechnology company that develops and commercializes medical applications based on the โ€ฆSee details»

BioStock akademi case: A1M Pharma | Du har väl inte missat

Du har väl inte missat BioStockakademin? Utbildningsserien som fördjupar sig i Life Science och läkemedelsutveckling. Nytt fördjupningscase med A1M...See details»

A1M Pharma announces positive top-line results ... - Guard โ€ฆ

A1M Pharma is listed on Nasdaq First North Growth Market Stockholm. The companyโ€™s Certified Advisor is Erik Penser Bank AB, tel. +46 (0)8-463 83 00, [email protected] . This โ€ฆSee details»

Green light for A1M Pharmaโ€™s Phase I study - Nordic Life Science

Nov 12, 2018 The Swedish Medical Products Agency grants A1M Pharma permission to start a Phase I study with the drug candidate ROSgard. In the first part of the study, which is โ€ฆSee details»

A1M Pharma : Swedish Medical Products Agency grants A1M โ€ฆ

Nov 9, 2018 Read PDF A1M Pharma announces today that the Swedish Medical Products Agency has granted permission to start a clinical Phase I study of ROSgardโ„ข - a drug โ€ฆSee details»

linkstock.net © 2022. All rights reserved